BioWorld MedTech

May 27, 2010

Compelling in registry results clinch clinical case for TAVI

PARIS – Transcatheter aortic valve implants (TAVI) have experienced a rapid take-up in Europe since the procedure was introduced in 2007. {Medical Device Daily} Read More

Docs weigh in on outlook for innovation & medical practice

Shuren takes aim at change of culture for Center for Devices

Survey: lawsuit fears hinder adoption of new med-tech

Report from Europe: Volcano wins CE mark for vascular imaging catheter

MDD's food for med tech thought

Deals roundup: Covidien to shed Specialty Chemicals for $280M in cash

People in the News

Patent watch: Applied Spine gets two patents expanding Stabilimax portfolio

Med-Tech's Next Great Opportunity: Obesity

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...